Mylan Inc exits 5.64 percent stake in Biocon via open market sale

FII holding declinedOwnership Changes View source PDF Explain this filing

BIOCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹437.00

prior close

₹436.50

announcement price

In-mkt

timing

Nifty Midcap 150market+0.4%-1.0% vs market

Pharmaceuticals peers, median of 165sector+0.0%-0.6% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Midcap 150 and 0.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.1

15m

+0.1

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6+0.4-1.0+0.0-0.6

Next day

+1.1+0.0+1.1+0.0+1.1

-0.1-0.4+0.3-1.1+1.0

-0.2+0.1-0.3-0.5+0.3

+0.8+0.5+0.3-0.4+1.2

+0.3-0.6+0.9-1.7+2.0

-0.8-1.6+0.8-2.6+1.9

15d

-2.7+1.5-4.2-1.1-1.6

-5.7+1.7-7.5-0.4-5.3

-12.6-3.0-9.6-0.3-12.3

-19.5-5.6-13.8-2.2-17.2

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mylan Inc sold 9,19,67,019 equity shares (5.64 percent) of Biocon Limited on 14 July 2026 through open market sale, disclosed under SEBI Takeover Regulations Reg 29(2). Mylan is not part of the promoter group. This represents a major exit by a foreign strategic shareholder.

Likely market impact

Full exit by a large foreign holder may pressure the stock. Investors should watch price action and demand absorbing this supply.